Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma

Cellular Oncology

Volumn 34, Issue 3, 2011, Pages 177-187

  Kausar, Tasneem ^a   Sharma, Rinu ^b   Hasan, Md Raghibul ^a   Saraya, Anoop ^a   Chattopadhyay, Tushar K ^a   Gupta, Siddartha Datta ^a   Ralhan, Ranju ^a,c,d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Esophageal cancer; Oncostatin M receptor ; Oncostatin M. Leukemia inhibitory factor ; SOSMR: A soluble form of oncostatin M receptor

Indexed keywords

LEUKEMIA INHIBITORY FACTOR RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR BETA; MESSENGER RNA; ONCOSTATIN M RECEPTOR BETA; UNCLASSIFIED DRUG; ONCOSTATIN M;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER MODEL; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CHEMISTRY; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA SUBUNIT; RECEPTORS, OSM-LIF; RNA, MESSENGER; UP-REGULATION;

EID: 84555178473     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0011-2     Document Type: Article

References (33)

1. IARC, Globocan 2002: cancer incidence, mortality and prevelance worldwide, version 1.0, IARC cancer base no. 5 (IARC Press, Lyon, 2005)
2. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Estimating the world cancer burden: Globocan 2000. Int J Cancer 2, 53-6 (2001)
3. N.M. Gupta, R. Jindal, O. Prakash, R. Gupta, D.K. Bhasin, Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 5, 400-4 (2001) (Pubitemid 32441904)
4. J.W.P.M. Van Baal, F. Milana, A.M. Rygiel, C.M.T. Sondermeijer, C.A.Spek, J.J.G.H. Bergman,M.P. Peppelenbosch,K.K.Krishnadath, A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol 30, 63-75 (2008) (Pubitemid 351161034)
5. R. Sharma, S. Samantaray, N.K. Shukla, R. Ralhan, Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 8, 481-8 (2003) (Pubitemid 36434223)
6. D.P. Gearing, M.R. Comeau, D.J. Friend, S.D. Gimpel, C.J. Thut et al., The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434-1437 (1992)
7. B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L.S. Park, D. Cosman, Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271, 32635-32643 (1996) (Pubitemid 27008685)
8. N. Underhill-Day, J.K. Heath, M. Oncostatin, (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel. Cancer Res 66, 10891-10901 (2006) (Pubitemid 44876987)
9. S.J. Levine, Mechanisms of soluble cytokine receptor generation. J Immunol 173, 5343-5348 (2004) (Pubitemid 39392116)
10. M. Honda, S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Osugi, T. Tokunaga, T. Kishimoto, Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148, 2175-2180 (1992)
11. S. Davis, T.H. Aldrich, N.Y. Ip, N. Stahl, S. Scherer, T. Farruggella, P.S. DiStefano, R. Curtis, N. Panayotatos, H. Gascan, S. Chevalier, G.D. Yancopoulos, Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 259, 1736-1739 (1993) (Pubitemid 23114657)
12. M. Narazaki, K. Yasukawa, T. Saito, Y. Ohsugi, H. Fukui, Y. Koishihara, G.D. Yancopoulos, T. Taga, T. Kishimoto, Soluble forms of the interleukin-6 signal-Transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82, 1120-1126 (1993) (Pubitemid 23253984)
13. N. Malik, J.C. Kallestad, N.L. Gunderson, S.D. Austin, M.G. Neubauer, V. Ochs, H. Marquardt, J.M. Zarling, M. Shoyab, C.M. Wei, Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9, 2847-2853 (1989) (Pubitemid 19163046)
14. T.J. Brown, M.N. Lioubin, H. Marquardt, Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol 139, 2977-2983 (1987) (Pubitemid 17157467)
15. S. Mori, K. Murakami-Mori, B. Bonavida, M. Oncostatin, (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor. Anticancer Res 19, 1011-1015 (1999) (Pubitemid 29257530)
16. J. Cai, P.S. Gill, R. Masood, P. Chandrasoma, B. Jung, R.E. Law, S.F. Radka, Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 145, 74-9 (1994) (Pubitemid 24217485)
17. García-Tuñón, M. Ricote, A. Ruiz, B. Fraile, R. Paniagua and M. Royuela, OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situ and in Infiltrative), Cancer invest. 26 (2008), 222-229. (Pubitemid 351328998)
18. R. Sharma, N. Sud, T.K. Chattopadhyay, R. Ralhan, TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology 69, 10-18 (2005) (Pubitemid 41207053)
19. J. Müllberg, E. Dittrich, L. Graeve, C. Gerhartz, K. Yasukawa, T. Taga, T. Kishimoto, P.C. Heinrich, S. Rose-John, Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 332, 174-178 (1993) (Pubitemid 23295922)
20. J. Müllberg, H. Schooltink, T. Stoyan, M. Günther, L. Graeve, G. Buse, A. Mackiewicz, P.C. Heinrich, S. Rose-John, The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23, 473-480 (1993) (Pubitemid 23075080)
21. K. Althoff, J. Müllberg, D. Aasland, N. Voltz, K. Kallen, J. Grötzinger, S. Rose-John, Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J 353, 663-672 (2001) (Pubitemid 32158335)
22. J.G. Zhang, Y. Zhang, C.M. Owczarek, L.D. Ward, R.L. Moritz, R.J. Simpson, K. Yasukawa, N.A. Nicola, Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem 273, 10798-10805 (1998) (Pubitemid 28227698)
23. S.A. Jones, P.J. Richards, J. Scheller, S. Rose-John, IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25, 241-253 (2005) (Pubitemid 40664421)
24. S. Pflanz, I. Tacken, J. Grötzinger, Y. Jacques, S. Minvielle, H. Dahmen, P.C. Heinrich, G. Müller-Newen, A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130. FEBS Lett 450, 117-122 (1999) (Pubitemid 29206722)
25. D. Aasland, B. Oppmann, J. Grötzinger, S. Rose-John, K.J. Kallen, The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex. J Mol Biol 315, 637-646 (2002) (Pubitemid 34729315)
26. C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, H. Gascan, Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor. J Biol Chem 281, 36673-36682 (2006) (Pubitemid 46042134)
27. D. Chen, C.Y. Chu, C.Y. Chen, H.C. Yang, Y.Y. Chiang, T.Y. Lin, I.P. Chiang, D.Y. Chuang, C.C. Yu, K.C. Chow, Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas. J Pathol 215, 290-299 (2008) (Pubitemid 351956710)
28. Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, N. Terakawa, Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M. Mol Hum Reprod 7, 665-670 (2001) (Pubitemid 32633416)
29. M. Friedrich, N. Höss, F. Stögbauer, V. Senner, W. Paulus, E.B. Ringelstein, H. Halfter, Complete inhibition of in vivo glioma growth by oncostatin M. J Neurochem 76, 1589-1592 (2000)
30. J.C. Szepietowski, C. Walker, D.B. McKenna, J.A. Hunter, R.C. McKenzie, Leukaemia inhibitory factor and interleukin-8 expression in nonmelanoma skin cancers. Clin Exp Dermatol 26, 72-78 (2001) (Pubitemid 32204851)
31. J. Liu, J.W. Li, Y. Gang, L. Guo, H. Li, Expression of leukemiainhibitory factor as an autocrinal growth factor in human medulloblastomas. J Cancer Res Clin Oncol 125, 475-480 (1999) (Pubitemid 29410411)
32. P. Kellokumpu-Lehtinen, M. Talpaz, D. Harris, Q. Van, R. Kurzrock, Z. Estrov, Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int J Cancer 66, 515-519 (1996) (Pubitemid 26176769)
33. Y. Wang, O. Robledo, E. Kinzie, F. Blanchard, C. Richards, A. Miyajima, H. Baumann, Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 275, 25273-85 (2000)